NCT05220241View on ClinicalTrials.gov

Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

August 1, 2025

Conditions
SARS-CoV-2 InfectionCognitive Disorder
Interventions
BIOLOGICAL

Nasopharyngeal swab for RT-PCR SARS-CoV-2

2 nasal swabs (one per nostril) of olfactory mucosa cells under local anesthesia for SARS-CoV-2 RT-PCR and pathological analysis

Trial Locations (2)

75010

NOT_YET_RECRUITING

Hôpital Lariboisière-Fernand-Widal, Paris

75019

RECRUITING

Hôpital Fondation A. de Rothschild, Paris

Sponsors

Collaborators (1)

Institut Pasteur
All Listed Sponsors
collaborator

Hotel Dieu Hospital

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

Hôpital Lariboisière Fernand Widal

OTHER

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK